Australia's peptide laws are stricter than most buyers realise. This guide explains the legal status of common research peptides, the realistic risks at customs, and how to use independent CoAs to filter out the vendors most likely to land you in trouble.
Most research peptides discussed online (semaglutide, tirzepatide, retatrutide, BPC-157, TB-500, CJC-1295, ipamorelin) are Schedule 4 prescription-only medicines in Australia under the Poisons Standard. They can only be legally supplied with a valid prescription from an Australian-registered prescriber, or to approved research facilities.
A small number of peptides (most notably GHRP-6 and certain MT-2 derivatives in some forms) sit higher up the schedules. Anabolic and growth-hormone substances are Schedule 4 and additionally controlled. Separate rules apply.
No. The TGA and Australian Border Force look at the substance, not the label. A vial of semaglutide marked "for research use only, not for human consumption" is still a Schedule 4 medicine entering Australia, and is still subject to the same import controls. The label is a vendor's legal shield, not yours.
Imports of Schedule 4 substances without an import permit and personal-import authorisation are routinely intercepted. The most common outcomes are:
This is why Australians should follow an applicable lawful pathway, such as the Personal Importation Scheme where all of its conditions are met, or obtain a medicine through an Australian prescriber and pharmacy in accordance with applicable rules.
Domestic vendors face less customs risk for buyers but more quality risk: a small, unregulated market with low scrutiny creates obvious incentives for under-dosed, mislabelled, or cross-contaminated product. Independent lab data is the only real filter.
Every result on labdoc.org/results is a third-party CoA: purity, identity, batch, lab name. Filter by Australia to see only domestic vendors with independent data. Vendors listed on LabDoc Verified have submitted ongoing third-party testing and accepted independent batch sampling.
Even with perfect lab data, "research peptide" supply chains are unregulated. Cold-chain breaks, mislabelled vials, and counterfeit substitution have all been documented in independent testing across the AU market. Independent CoAs reduce risk; they don't eliminate it.